Kaustuv Bhattacharya

Kaustuv Bhattacharya is an Assistant Professor in the Department of Pharmacy Administration and a Research Assistant Professor in the Center for Pharmaceutical Marketing and Management at the University of Mississippi School of Pharmacy. His work bridges pharmaceutical sciences and health outcomes research, with a strong emphasis on real-world data analysis and patient-centered care.

Education:

• B.S. Pharmacy, Jadavpur University (2012)
• M.S. Pharmaceutical Science, The University of Mississippi (2017)
• Ph.D. Pharmaceutical Science, The University of Mississippi (2020)

Dr. Bhattacharya's research focuses on pharmacoepidemiology, pharmacoeconomics, and health outcomes across chronic diseases such as cancer, cardiovascular conditions, obesity, and rare genetic disorders. His work frequently involves secondary data analysis of large administrative databases to assess economic, clinical, and humanistic outcomes. A growing area of interest is financial toxicity in cancer survivors and its impact on patients and caregivers.

The recent publications reflect a consistent trend in evaluating healthcare disparities, treatment costs, medication safety, and implementation of precision medicine. Key themes include gender disparities in osteoporosis care, economic burden of multiple myeloma, opioid-related respiratory risks in COPD, and underutilization of pharmacogenetic testing.

Professional Engagement:

• Active member of AMCP (Academy of Managed Care Pharmacy)
• Member of SER (Society for Epidemiologic Research)
• Member of ISPOR (International Society for Pharmacoeconomics and Outcomes Research)

Dr. Bhattacharya has been involved in research funded by government agencies and the pharmaceutical industry. He serves as a faculty instructor and teaches PHAD 687: Secondary Data Techniques, training students in real-world evidence methods. He advises graduate students in the Pharmaceutical Sciences (M.S. and Ph.D.) programs, though specific advisees are not listed.

He is affiliated with the Center for Pharmaceutical Marketing and Management, where he contributes to research on pharmaceutical policy and market access. His work supports evidence-based decision-making in managed care and public health policy.